RxDoctor Payments Data
★ My doctorsLook up a doctor →

Djurabek Babadjanov, MD

Vascular Surgery · Newport News, VANPI 1740421049

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.0%), grants and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 61.3% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $7,449 and has fallen 69.9% since, to $2,239 in 2025.

$15,167in general payments, 2019–2025

Across 234 payments — averaging $64.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • W. L. Gore & Associates, Inc.$2K
  • Inari Medical, Inc.$1K
  • Stryker$417
  • Silk Road Medical, Inc.$268
  • Johnson & Johnson$267
  • plus $2K from 20 others

What the payments were for

  • Grants$5,70038%
  • Travel & lodging$8856%
  • Food & beverage$8,49456%
  • Education$881%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)94$9,301
W. L. Gore & Associates, Inc.30$2,106
Inari Medical, Inc.33$1,100
Stryker10$417
Silk Road Medical, Inc.3$268
Johnson & Johnson15$267
Veryan Medical Incorporated2$247
Shockwave Medical, Inc2$206
Abbott2$173
Cook Medical LLC4$166
Penumbra, Inc.7$152
Boston Scientific2$120
Pfizer6$117
Cordis US CORP.3$94
Bard Peripheral Vascular, Inc.3$60
Philips North America LLC1$50
Convatec Inc.3$47
Microvention, Inc.2$46
Kerecis Limited2$43
Getinge USA Sales, LLC2$41
Acell, Inc.2$40
Terumo Medical Corporation2$33
Integra Lifesciences Corporation1$21
Teleflex LLC1$19
Normatec Industries, LP1$17
Angiodynamics, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,167 in reported general payments places this provider in the 65th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia →

Medicare billing

Part B allowed, 2024
$182,516
Medicare patients
1,040
Services billed
1,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate64$771
Gabapentin11$168
Oxycodone Hcl57$156

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Newport News

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →